Updated: Nov 1, 2007
Gamekeeper's thumb is an insufficiency of the ulnar collateral ligament (UCL) of the metacarpophalangeal (MCP) joint of the thumb. Campbell originally coined the term in 1955 because the condition was most commonly associated with Scottish gamekeepers (especially rabbit keepers) as a work-related injury.1 The injury occurred as the gamekeepers sacrificed game such as rabbits by breaking the animals' necks between the thumb and index finger of the gamekeeper and the ground. As a result, a valgus force was placed onto the abducted metacarpophalangeal (MCP) joint, leading to a ruptured ulnar collateral ligament (UCL) injury and chronic attritional injury that resulted in instability, which was accompanied by pain and weakness of the pinch grasp. (See also the eMedicine article Gamekeeper Thumb.)
In the present day, this type of injury is typically more acute. The most common cause is a skier's hand landing on a ski pole, causing a valgus force on the thumb.2 The term "skier's thumb" represents the more acute nature of the injury. Because stability of the thumb is important for prehension, treatment is directed toward optimizing ligament healing to restore full function. (See also the eMedicine article Skier's Thumb.)
For excellent patient education resources, visit eMedicine's Hand, Wrist, Elbow, and Shoulder Center and Sports Injury Center. Also, see eMedicine's patient education article Skier's Thumb and Repetitive Motion Injuries.
Gamekeeper's thumb is a fairly common injury, with an increased incidence in skiers that does not depend on the type of ski pole used. No known sex predilection is associated with this condition.
No apparent difference exists in the international population with regard to the frequency or incidence of gamekeeper's thumb.
The UCL is a 4- to 8-mm X 12- to 14-mm band that originates from the metacarpal head and inserts into the medial aspect and base of the proximal phalanx of the thumb. Occasionally, when the UCL is strained, it avulses the bone at its insertion and leads to a gamekeeper's fracture (see Images 1-2).
A Stener lesion occurs when the adductor aponeurosis becomes interposed between the ruptured UCL and its site of insertion at the base of the proximal phalanx. Thus, the distal portion of the ligament retracts and points superficially and proximally. A rupture of the proper and accessory collateral ligaments must occur for this injury to happen. The UCL no longer contacts its area of insertion and cannot heal. This lesion can also be associated with a gamekeeper's fracture,3 which can be subtle or obvious (see Images 1-2). However, a lump or mass over the ulnar aspect of the MCP joint of the thumb does not necessarily imply a fracture; it may be the result of the Stener lesion. (See also the eMedicine article Stener Lesion.)
Considerable variation may be observed in the range of flexion and extension of the thumb MCP joint. The variation of normal joints can include ranges of motion (ROMs) from 5-115° of flexion and extension. In full extension, valgus laxity averages 6° and increases to an average of 12° in 15° of flexion.
The gamekeeper's thumb injury may be caused by a valgus stress of any kind to the thumb. The most common history is a fall onto an outstretched arm with an abducted thumb. This commonly occurs in skiers with a ski pole in the hand, which prevents adduction of the thumb when the skier falls.
Metacarpophalangeal Joint Dislocation
Phalangeal Fractures
Skier's Thumb
All complete UCL tears require operative intervention. An incision is made over the ulnar border of the MCP joint of the thumb. The adductor aponeurosis is incised longitudinally and retracted distally. The dorsal capsule is then exposed, and the proper and accessory collateral ligaments are assessed. If the joint is subluxed and if the soft-tissue repair seems insufficient to hold the reduced joint, a small-gauge Kirschner wire (ie, K-wire) can be inserted to maintain the MCP joint in position. The UCL can then be repaired. If a small piece of avulsed bone is present, remove it; a large bone fragment should be reduced and preserved.
For small, nondisplaced avulsion fractures of the proximal phalanx that are found to be stable on stress testing, nonoperative treatment by a spica-type cast for 4 weeks can be completed with good results.
Postoperatively, the patient is immobilized in a thumb spica cast for 4 weeks. At 4 weeks, the cast and any pins that were placed may be removed. The patient is then placed in a hand-based splint that immobilizes the MCP joint for 2 weeks. The splint is removed for therapy during this 2-week period, and active motion of the MCP joint is begun. Unrestricted usage is allowed at 3 months.
Chronic instability is difficult to treat. Limited success has been associated with repair of gamekeeper's thumb injuries using the capsuloligamentous structures on the ulnar border of the MCP joint.
Nonsteroidal anti-inflammatory drugs (NSAIDs), which decrease pain and swelling, are the drugs of choice (DOC) in the acute phase of a gamekeeper's thumb injury. The anti-inflammatory effects decrease the acute swelling that is associated with this condition, allowing for a better examination at follow-up (if necessary).
NSAIDs are nonopioid analgesics that are made up of different compounds but classed together based solely on their clinical effects. They typically work by inhibiting the formation of prostaglandins through the cyclooxygenase pathway. NSAIDs do not promote dependence like the opioid agents, but they can be associated with renal, liver, and gastrointestinal (GI) toxicities.
Pain control and anti-inflammatory effects are essential to the quality of patient care. They are beneficial to patients who have a painful injury.
DOC for mild to moderate pain. Inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis.
400 mg q4-6h, 600 mg q6h, or 800 mg q8h PO while symptoms persist; not to exceed 3.2 g/d
6 months to 12 years: 20-40 mg/kg/d divided tid or qid
>12 years: Administer as in adults
May decrease the effects of loop diuretics with coadministration; coadministration with anticoagulants may increase PT duration (monitor and watch for signs of bleeding); may increase serum lithium levels and increase the risk of methotrexate toxicity; probenecid may increase toxicity of NSAIDs
Documented hypersensitivity; avoid in patients with peptic ulcer disease, recent GI bleeding or perforation, renal insufficiency, and high risk of bleeding
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Caution in patients with congestive heart failure, hypertension, and decreased renal and hepatic function; caution in the presence of anticoagulation abnormalities or during anticoagulant therapy
For relief of mild to moderate pain; inhibits inflammatory reactions and pain by decreasing the activity of cyclooxygenase, which is responsible for prostaglandin synthesis.
500 mg PO, followed by 250 mg q6-8h; not to exceed 1.25 g/d; may increase to 1.5 g/d for limited time periods
< 2 years: Not established
> 2 years: 2.5 mg/kg/dose PO; not to exceed 10 mg/kg/d
Probenecid may increase the toxicity of NSAIDs; coadministration with ibuprofen may decrease the effects of loop diuretics; coadministration with anticoagulants may prolong PT duration (watch for signs of bleeding); NSAIDs may increase serum lithium levels and increase the risk of methotrexate toxicity (eg, stomatitis, bone marrow suppression, nephrotoxicity)
Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Acute renal insufficiency, interstitial nephritis, hyperkalemia, hyponatremia, and renal papillary necrosis may occur; patients with preexisting renal disease or compromised renal perfusion risk acute renal failure; leukopenia occurs rarely, is transient, and usually returns to normal during therapy; persistent leukopenia, granulocytopenia, or thrombocytopenia warrant further evaluation and may require discontinuation of the drug
Although increased cost can be a negative factor in the use of COX-2 inhibitors, the incidence of costly and potentially fatal GI bleeds is clearly less with COX-2 inhibitors than with traditional NSAIDs. Ongoing analysis of the cost avoidance of GI bleeds will further define the populations that will find these agents the most beneficial.
Celecoxib inhibits primarily COX-2. COX-2 is considered an inducible isoenzyme, induced during pain and inflammatory stimuli. Inhibition of COX-1 may contribute to NSAID GI toxicity. At therapeutic concentrations, the COX-1 isoenzyme is not inhibited, thus GI toxicity may be decreased. Seek the lowest dose of celecoxib for each patient.
200 mg/d PO qd; alternatively, 100 mg PO bid
Not established
Coadministration with fluconazole may cause an increase in celecoxib plasma concentrations because of inhibition of the celecoxib metabolism; coadministration of celecoxib with rifampin may decrease celecoxib plasma concentrations
Documented hypersensitivity to sulfonamides
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
May cause fluid retention and peripheral edema; caution in patients with compromised cardiac function, hypertension, conditions predisposing to fluid retention; caution in the presence of severe heart failure and hyponatremia because circulatory hemodynamics may deteriorate; NSAIDs may mask the usual signs of infection; caution in the presence of existing controlled infections; evaluate symptoms and signs that suggest liver dysfunction, or in abnormal liver laboratory results
After surgical repair, the MCP joint is immobilized in a cast for 4 weeks. After this period, the cast is removed and replaced with a removable thumb spica splint so that MCP motion can begin. This is continued for 2 weeks; then the splint is removed completely so the MCP joint can be fully mobilized. Unrestricted usage and return to sports can begin at 3 months.
Patients are not recommended to return to sports that may stress the hand before 3 months have passed. Premature return to full activity can stress the repair or reconstruction and cause chronic joint instability, which is then very difficult to treat. Chronic pain and degeneration can then develop at the MCP joint of the thumb.
Chronic instability of the MCP joint can occur despite a good surgical repair, especially if motion and return to play are resumed prematurely. This instability is difficult to treat and can lead to arthritic changes in the MCP joint, as well as weak pinch grasp in the long term.
Currently, there are no proven accessories for the prevention of Gamekeeper's thumb injuries. Ski gloves are being designed to protect the thumbs during skiing, but these have not yet been proven effective.
Early diagnosis of Gamekeeper's thumb injuries is one of the most important factors that determines functional outcome. In thumbs with partial ligament injuries, nonoperative treatment by immobilization will yield a stable, painless thumb with nearly normal motion in most cases. In thumbs with a complete rupture that are treated operatively within 3 weeks of injury, a good to excellent result can be expected in >90% of cases.
Pain and stiffness in the affected thumb can be expected to be mild or absent, and pinch and grip strength should be nearly normal. The rate of return to former activities, including recreational sports, has been reported as high as 96%.
Campbell CS. Gamekeeper's thumb. J Bone Joint Surg Br. Feb 1955;37-B(1):148-9. [Medline]. [Full Text].
Newland CC. Gamekeeper's thumb. Orthop Clin North Am. Jan 1992;23(1):41-8. [Medline].
Bekler H, Gokce A, Beyzadeoglu T. Avulsion fractures from the base of phalanges of the fingers. Tech Hand Up Extrem Surg. Sep 2006;10(3):157-61. [Medline].
Heyman P. Injuries to the ulnar collateral ligament of the thumb metacarpophalangeal joint. J Am Acad Orthop Surg. Jul 1997;5(4):224-9. [Medline].
Baskies MA, Tuckman D, Paksima N, Posner MA. A new technique for reconstruction of the ulnar collateral ligament of the thumb. Am J Sports Med. Aug 2007;35(8):1321-5. [Medline].
Shinohara T, Horii E, Majima M, et al. Sonographic diagnosis of acute injuries of the ulnar collateral ligament of the metacarpophalangeal joint of the thumb. J Clin Ultrasound. Feb 2007;35(2):73-7. [Medline].
Peterson JJ, Bancroft LW. Injuries of the fingers and thumb in the athlete. Clin Sports Med. Jul 2006;25(3):527-42, vii-viii. [Medline].
Pichora DR, McMurtry RY, Bell MJ. Gamekeepers thumb: a prospective study of functional bracing. J Hand Surg [Am]. May 1989;14(3):567-73. [Medline].
Sollerman C, Abrahamsson SO, Lundborg G, Adalbert K. Functional splinting versus plaster cast for ruptures of the ulnar collateral ligament of the thumb. A prospective randomized study of 63 cases. Acta Orthop Scand. Dec 1991;62(6):524-6. [Medline].
Maheshwari R, Sharma H, Duncan RD. Metacarpophalangeal joint dislocation of the thumb in children. J Bone Joint Surg Br. Feb 2007;89(2):227-9. [Medline].
Abrahamsson SO, Sollerman C, Lundborg G, Larsson J, Egund N. Diagnosis of displaced ulnar collateral ligament of the metacarpophalangeal joint of the thumb. J Hand Surg [Am]. May 1990;15(3):457-60. [Medline].
Gerber C, Senn E, Matter P. Skier's thumb. Surgical treatment of recent injuries to the ulnar collateral ligament of the thumb's metacarpophalangeal joint. Am J Sports Med. May-Jun 1981;9(3):171-7. [Medline].
Stener B. Displacement of the ruptured ulnar collateral ligament of the metacarpo-phalangeal joint of the thumb. J Bone Joint Surg [Br]. July 1962;44:869-79. [Full Text].
instability of the thumb, skier's thumb, Stener lesion, ulnar collateral ligament tear, UCL tear, proper collateral ligament tear, thumb injury, thumb pain
Matthew Hannibal, MD, Staff Physician, Department of Orthopedics, St Mary's Medical Center
Disclosure: Nothing to disclose.
Daniel Roger, MD, Assistant Professor, Department of Orthopedics, Catholic Medical Center of Brooklyn and Queens, New York Medical College
Daniel Roger, MD is a member of the following medical societies: Medical Society of the State of New York
Disclosure: Nothing to disclose.
Gerard A Malanga, MD, Associate Professor, Department of Physical Medicine and Rehabilitation, New Jersey Medical School; Director of Pain Management, University of Medicine and Dentistry at New Jersey, Overlook Hospital; Director of Sports Medicine, Mountainside Hospital
Gerard A Malanga, MD is a member of the following medical societies: American Academy of Pain Medicine, American Academy of Physical Medicine and Rehabilitation, American College of Sports Medicine, North American Spine Society, and Physiatric Association of Spine, Sports and Occupational Rehabilitation
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.
Jon B Whitehurst, MD, Clinical Instructor of Surgery, University of Illinois College of Medicine; Partner and Executive Board Member, Rockford Orthopedic Associates; Orthopedic Chairman, Rockford Memorial Hospital
Jon B Whitehurst, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, and Arthroscopy Association of North America
Disclosure: Nothing to disclose.
Craig C Young, MD, Professor, Departments of Orthopedic Surgery and Community and Family Medicine, Medical Director of Sports Medicine, Sports Medicine Fellowship Director, Medical College of Wisconsin
Craig C Young, MD is a member of the following medical societies: American Academy of Family Physicians, American College of Sports Medicine, American Medical Society for Sports Medicine, Phi Beta Kappa, and Wilderness Medical Society
Disclosure: Nothing to disclose.
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)